Acorda Therapeutics Inc (ACOR.O)
ACOR.O on Nasdaq
37.26USD
1 Aug 2013
37.26USD
1 Aug 2013
Price Change (% chg)
$-0.71 (-1.87%)
$-0.71 (-1.87%)
Prev Close
$37.97
$37.97
Open
$37.97
$37.97
Day's High
$38.43
$38.43
Day's Low
$36.00
$36.00
Volume
510,666
510,666
Avg. Vol
340,436
340,436
52-wk High
$40.87
$40.87
52-wk Low
$21.33
$21.33
About
Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical company. The Company is engaged in the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system.... (more)
Overall
| Beta: | 0.85 |
| Market Cap (Mil.): | $1,540.29 |
| Shares Outstanding (Mil.): | 40.57 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ACOR.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 10.57 | 47.13 | 37.76 |
| EPS (TTM): | 3.59 | -- | -- |
| ROI: | 37.79 | -2.58 | 18.76 |
| ROE: | 47.80 | -2.66 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Biogen Idec Inc (BIIB.OQ) | $220.22 | +2.09 |
| Teva Pharmaceutical Industries Limited (TEVA.TA) | 13,920.00₪ | -200.00 |
| Elan Corporation, plc (ELN.I) | €11.64 | +0.05 |
| Novartis AG (NOVN.VX) | CHF66.60 | +0.35 |
| BioMarin Pharmaceutical Inc. (BMRN.OQ) | $64.67 | +0.02 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

